Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Research Report 2025(Status and Outlook)

Report Overview

Continuous Glucose Monitoring (CGM) Systems for Diabetics are wearable devices that track glucose levels throughout the day and night. These systems consist of a sensor placed under the skin, which continuously measures glucose levels in the interstitial fluid. The sensor is connected to a transmitter that sends the data to a receiver or smartphone app, providing real-time glucose readings and trends. CGM systems help individuals with diabetes monitor their glucose levels more effectively than traditional fingerstick testing, enabling better management of blood sugar levels and reducing the risk of complications.

The market for Continuous Glucose Monitoring (CGM) Systems for Diabetics is experiencing significant growth driven by several key factors. One of the primary market trends is the increasing prevalence of diabetes worldwide, particularly type 1 and type 2 diabetes. As the number of individuals diagnosed with diabetes continues to rise, there is a growing need for advanced monitoring solutions like CGM systems to help manage the condition effectively. Additionally, technological advancements in CGM systems, such as improved accuracy, ease of use, and integration with other digital health platforms, are driving market growth. These innovations are making CGM systems more attractive to both healthcare providers and patients, leading to greater adoption rates.

At the same time, the shift towards personalized medicine and value-based healthcare is also fueling the demand for Continuous Glucose Monitoring (CGM) Systems for Diabetics. Healthcare providers are increasingly focusing on preventive care and individualized treatment plans to improve patient outcomes and reduce healthcare costs. CGM systems play a crucial role in this paradigm shift by providing real-time data that allows for personalized adjustments to medication, diet, and lifestyle choices. As a result, CGM systems are becoming an essential tool in the management of diabetes, driving their adoption across various healthcare settings.

This report provides a deep insight into the global Continuous Glucose Monitoring (CGM) Systems for Diabetics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Continuous Glucose Monitoring (CGM) Systems for Diabetics market in any manner.

Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Diabetes Care Inc.

Dexcom

Medtronic

Senseonics Holdings

GlySens Incorporated

Meiqi Medical Equipment

San Meditech

Market Segmentation (by Type)

Wearable

Implantable

Market Segmentation (by Application)

Hospitals & Clinics

Homecare Settings

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Continuous Glucose Monitoring (CGM) Systems for Diabetics Market

Overview of the regional outlook of the Continuous Glucose Monitoring (CGM) Systems for Diabetics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Continuous Glucose Monitoring (CGM) Systems for Diabetics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Continuous Glucose Monitoring (CGM) Systems for Diabetics
1.2 Key Market Segments
1.2.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Segment by Type
1.2.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Overview
2.1 Global Market Overview
2.1.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Life Cycle
3.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Manufacturers (2020-2025)
3.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Manufacturers (2020-2025)
3.5 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Sites, Area Served, Product Type
3.8 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competitive Situation and Trends
3.8.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Continuous Glucose Monitoring (CGM) Systems for Diabetics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Chain Analysis
4.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Continuous Glucose Monitoring (CGM) Systems for Diabetics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Continuous Glucose Monitoring (CGM) Systems for Diabetics Market
5.8 ESG Ratings of Leading Companies
6 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Type (2020-2025)
6.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Market Share by Type (2020-2025)
6.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price by Type (2020-2025)
7 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Sales by Application (2020-2025)
7.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size (M USD) by Application (2020-2025)
7.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Growth Rate by Application (2020-2025)
8 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Sales by Region
8.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region
8.1.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region
8.1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Region
8.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region
8.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region
8.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Market Share by Region
8.3 North America
8.3.1 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
8.3.2 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
8.4.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region
8.5.2 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country
8.6.2 South America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region
8.7.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Production by Region
9.1 Global Production of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Region(2020-2025)
9.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Region (2020-2025)
9.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Production
9.4.1 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Production Growth Rate (2020-2025)
9.4.2 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Production
9.5.1 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Production Growth Rate (2020-2025)
9.5.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Production (2020-2025)
9.6.1 Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Production Growth Rate (2020-2025)
9.6.2 Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Continuous Glucose Monitoring (CGM) Systems for Diabetics Production (2020-2025)
9.7.1 China Continuous Glucose Monitoring (CGM) Systems for Diabetics Production Growth Rate (2020-2025)
9.7.2 China Continuous Glucose Monitoring (CGM) Systems for Diabetics Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Abbott Diabetes Care Inc.
10.1.1 Abbott Diabetes Care Inc. Basic Information
10.1.2 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.1.3 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.1.4 Abbott Diabetes Care Inc. Business Overview
10.1.5 Abbott Diabetes Care Inc. SWOT Analysis
10.1.6 Abbott Diabetes Care Inc. Recent Developments
10.2 Dexcom
10.2.1 Dexcom Basic Information
10.2.2 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.2.3 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.2.4 Dexcom Business Overview
10.2.5 Dexcom SWOT Analysis
10.2.6 Dexcom Recent Developments
10.3 Medtronic
10.3.1 Medtronic Basic Information
10.3.2 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.3.3 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.3.4 Medtronic Business Overview
10.3.5 Medtronic SWOT Analysis
10.3.6 Medtronic Recent Developments
10.4 Senseonics Holdings
10.4.1 Senseonics Holdings Basic Information
10.4.2 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.4.3 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.4.4 Senseonics Holdings Business Overview
10.4.5 Senseonics Holdings Recent Developments
10.5 GlySens Incorporated
10.5.1 GlySens Incorporated Basic Information
10.5.2 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.5.3 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.5.4 GlySens Incorporated Business Overview
10.5.5 GlySens Incorporated Recent Developments
10.6 Meiqi Medical Equipment
10.6.1 Meiqi Medical Equipment Basic Information
10.6.2 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.6.4 Meiqi Medical Equipment Business Overview
10.6.5 Meiqi Medical Equipment Recent Developments
10.7 San Meditech
10.7.1 San Meditech Basic Information
10.7.2 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Overview
10.7.3 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Market Performance
10.7.4 San Meditech Business Overview
10.7.5 San Meditech Recent Developments
11 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Forecast by Region
11.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Forecast
11.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Forecast by Country
11.2.3 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Forecast by Region
11.2.4 South America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Type (2026-2033)
12.1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Type (2026-2033)
12.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Forecast by Application (2026-2033)
12.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units) Forecast by Application
12.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings